What You Should Know:
- After a strong start to the year, the digital health sector experienced a significant pullback in Q2 2025, with deal volume declining to its lowest quarterly activity level in the last five years, according to the latest report from Silicon Valley Bank (SVB).
- The report, Mid-Year Healthcare Investment and Exits Report reveals growing investor selectivity and capital concentration in fewer, high-conviction bets amidst ongoing global economic
Read More
Life Sciences | News, Analysis, Insights - HIT Consultant
Briya Launches AIRE™: The World’s First Clinical-Grade AI Research Assistant to Accelerate Biomedical Discovery
What You Should Know:
- Briya, a health technology company redefining medical research launches Briya AIRE™, the world's first clinical-grade AI research assistant built to accelerate biomedical and clinical decision-making.
- Designed to "think" in the language of medicine, clinical research, and epidemiology, AIRE aims to transform months of manual data analysis into actionable insights in minutes, enabling faster, cost-effective discovery across biopharma and academic research
Read More
Neurogen Biomarking Virtual Care Ecosystem Cuts Time to Alzheimer’s Intervention by 4.5 Years
What You Should Know:
- Advancements in accelerating early Alzheimer’s disease (AD) screening and access to care, proven from three diverse community pilot initiatives, were presented today during a podium presentation at the Alzheimer’s Association International Conference® 2025 (AAIC). The study, entitled “Remote Collection of Biomarkers for Alzheimer’s Disease and Related Disorders,” validated Neurogen’s new ecosystem, which brings together the first in-home blood biomarker testing
Read More
Flatiron Health Triples Global Oncology Research Network
What You Should Know:
- Flatiron Health, a leading healthtech company dedicated to improving cancer care and advancing research using real-world data (RWD), today announced that its international oncology research network has tripled in size across the UK, Germany, and Japan over the past year—a milestone that marks an unprecedented acceleration in global cancer research collaboration and impact.
- Flatiron Health entered international markets to address the growing unmet need for
Read More
Sanofi Acquires Vicebio for $1.15B, Bolstering Vaccine Pipeline
What You Should Know:
- Sanofi has entered into an agreement to acquire Vicebio Ltd (“Vicebio”), a privately held biotechnology company headquartered in London, UK. The acquisition expands Sanofi’s capabilities in vaccine design and development with Vicebio’s innovative ‘Molecular Clamp’ technology and brings an early-stage combination vaccine candidate for respiratory syncytial virus (RSV) and human metapneumovirus (hMPV) into its pipeline.
- The vaccine candidate complements
Read More
Unlocking the Power of Genomics in Clinical Trials: A Precision Medicine Data Imperative
As precision medicine continues to reshape the future of healthcare, clinical trials are evolving from one-size-fits-all studies into highly targeted investigations driven by genomics and biomarker-based insights. These trials not only test therapeutic efficacy but also help identify which patients are most likely to benefit, reducing trial-and-error in treatment and transforming hope into more predictable outcomes. With nearly half a million clinical trials underway globally, the potential to
Read More
Navigating Clinical Trials: Physicians Face Major Hurdles in Accessing Innovative Treatments
What You Should Know:
- myTomorrows, a global health technology company connecting patients and physicians with pre-approval treatments, published a new data report, "Searching for solutions: How physicians navigate trial access and technology."
- Based on a survey of 100 U.S.-based healthcare professionals, the report reveals that 61% of physicians find the process of identifying and accessing relevant clinical trials difficult, and 72% specifically find clinical trial
Read More
Define Ventures Report Reveals Pharma Accelerates AI Investment for Enterprise-Scale Deployment
What You Should Know:
- Define Ventures, one of the largest venture capital firms focused on early-stage health tech companies, today released a report revealing how Big Pharma is accelerating investment in AI to counter rising cost pressure, regulatory shifts, and growing competitive urgency.
- The report is based on in-depth surveys and interviews with over 40 executives, including leaders from 16 of the top 20 pharma companies and major players like Amazon Web Services,
Read More
Patient-Centric Approaches in an Era of Multi-Indication Therapies
The life sciences industry has undergone a profound transformation over the past decade, evolving from a product-centric model to one that places patients at the center of its business strategy. This shift toward patient-centricity coincides with the rise of multi-indication therapies — treatments approved to address multiple conditions — to create a dynamic landscape that benefits both patients and life sciences companies alike.
The advent of patient-centricity
Patient-centricity requires
Read More
Century Health Brings AI Curated Datasets to Life Sciences Companies Through Datavant Connect and AWS Clean Rooms
What You Should Know:
- Century Health has announced a strategic partnership with Datavant Connect—powered by AWS Clean Rooms—to bring AI-curated, disease-specific datasets directly to pharmaceutical and life sciences companies through a secure, no-data-movement platform.
- By joining Datavant’s Lighthouse Partner Program, Century Health enables researchers to discover and assess high-quality, longitudinal clinical data in minutes—not months—without accessing or transferring sensitive
Read More
